Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Great Point Partners, LLC | 18,000 1.420% |
-97,317 (-84.39%) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | NextCure, Inc. NXTC |
Great Point Partners, LLC | 0 0.000% |
-1,376,532 (Position Closed) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | TG Therapeutics, Inc. TGTX |
Great Point Partners, LLC | 0 0.000% |
-5,434,783 (Position Closed) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Zymeworks Inc. ZYME |
Great Point Partners, LLC | 799,722 1.750% |
-1,424,067 (-64.04%) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Prothena Corporation plc PRTA |
Great Point Partners, LLC | 977,647 2.450% |
-1,123,294 (-53.47%) |
Filing History |
| 2021-02-16 4:13 pm Unchanged |
2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE |
Great Point Partners, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-07-07 5:27 pm Purchase |
2020-07-07 | 13G | Abeona Therapeutics Inc. ABEO |
Great Point Partners, LLC | 339,555 9.990% |
336 (+0.10%) |
Filing History |